1. Dores GM, Devesa SS, Curtis RE, Linet MS, Morton LM . Acute leukemia incidence and patient survival among children and adults in the United States, 2001–2007. Blood 2012; 119: 34–43.
2. Grimwade D, Howe K, Langabeer S, Davies L, Oliver F, Walker H et al. Establishing the presence of the t(15;17) in suspected acute promyelocytic leukaemia: cytogenetic, molecular and PML immunofluorescence assessment of patients entered into the M.R.C. ATRA trial. M.R.C. Adult Leukaemia Working Party. Br J Haematol 1996; 94: 557–573.
3. Grimwade D, Biondi A, Mozziconacci MJ, Hagemeijer A, Berger R, Neat M et al. Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Groupe Français de Cytogénétique Hématologique, Groupe de Français d'Hematologie Cellulaire, UK Cancer Cytogenetics Group and BIOMED 1 European Community-Concerted Action ‘Molecular Cytogenetic Diagnosis in Haematological Malignancies’. Blood 2000; 96: 1297–1308.
4. Campbell LJ, Oei P, Brookwell R, Shortt J, Eaddy N, Ng A et al. FISH detection of PML-RARA fusion in ins(15;17) acute promyelocytic leukaemia depends on probe size. Biomed Res Int 2013; 2013: 164501.
5. Chen SJ, Chen Z, Chen A, Tong JH, Dong S, Wang ZY et al. Occurrence of distinct PML-RARalpha fusion gene isoforms in patients with acute promyelocytic leukemia detected by reverse transcriptase polymerase chain reaction. Oncogene 1992; 7: 1223–1232.